녹십자 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 최영일, was filed 07 Aug 2026.
녹십자: what insiders have been doing
녹십자 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Between 1 November 2025 and 1 November 2026, 5 insiders published 6 filings.
Open-market activity splits into 3 purchases and 2 sales; 3 insiders sit on the buying side and 1 insider on the selling side. No amount is published for 5 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 3 senior executives among the declarants.
With 6 filings in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 17 purchases and 4 sales.
The clock since the last published purchase (7 August 2026) now reads 95 days.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -2.8%Entry ₩121,900 · Close at T+365 ₩118,500
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate 녹십자 Buy (bullish), based on 8 analysts. Average price target: ₩191,000.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 500 sharesShareKRXDART:20260807000521Canonical exit: 5 Nov 2026 (T+90)
- 118,873 sharesKRXDART:20260701000359
- 250 sharesShareKRXDART:20260622000267Canonical exit: 20 Sept 2026 (T+90)
- ●Executives0DART
- 25 sharesShareKRXDART:20260107000555Canonical exit: 7 Apr 2026 (T+90)
- 241,830 sharesKRXDART:20260102000203
- ●Executives0DART
- 55,092 sharesShareKRXDART:20250108000025Canonical exit: 8 Apr 2025 (T+90)
- 347 sharesShareKRXDART:20250107000410Canonical exit: 7 Apr 2025 (T+90)
- 80 sharesShareKRXDART:20250107000399Canonical exit: 7 Apr 2025 (T+90)
- 1,175,570 sharesShareKRXDART:20241205000191Canonical exit: 5 Mar 2025 (T+90)
- 14,647 sharesShareKRXDART:20241122000313
- ShareKRXDART:20241008000560
- 274,828 sharesKRXDART:20241007000193Canonical exit: 30 Oct 2024 (T+90)
- ShareKRXDART:20240913000756Canonical exit: 8 Dec 2024 (T+90)
- ShareKRXDART:20240913000481Canonical exit: 11 Dec 2024 (T+90)
- ShareKRXDART:20240906000612Canonical exit: 20 Sept 2023 (T+90)
- ShareKRXDART:20240703000493Canonical exit: 17 Apr 2024 (T+90)
- ●Executives0DART
- ShareKRXDART:20230619000188
- ShareKRXDART:20230602000271
- ShareKRXDART:20230512000444
- ●Executives0DART
- 71 shares@ ₩138,147.8873100.0% of flowShareKRXDART:20230222002503Canonical exit: 7 Jul 2022 (T+90)
- ShareKRXDART:20220408002826
25 of 39 declarations
About 녹십자
녹십자 is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX stock exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
